Oncology: Endocrine

You have access
First-in-human study of novel SSTR antagonist ¹⁷⁷Lu-DOTA-LM3 for peptide receptor radionuclide therapy in patients with metastatic neuroendocrine neoplasms: dosimetry, safety and efficacy
Richard P. Baum, Jingjing Zhang, Christiane Schuchardt, Dirk Mueller and Helmut Maecke

Journal of Nuclear Medicine March 5, 2021, jnumed.120.258889; DOI: https://doi.org/10.2967/jnumed.120.258889
You have access
A Prospective Randomized, Double-blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of ⁶⁸Ga-NODAGA-LM3 and ⁶⁸Ga-DOTA-LM3 in Patients with Well-differentiated Neuroendocrine Tumors
li huo, Wenjia Zhu, Yuejuan Cheng, Ru Jia, Hong Zhao, Chunmei Bai, Jianming Xu and Shaobo Yao

Journal of Nuclear Medicine February 12, 2021, jnumed.120.253096; DOI: https://doi.org/10.2967/jnumed.120.253096
Open Access
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker
David L Chan, Gary A Ulaner, David A. Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T Li, W. Victoria Lai, Nick Pavlakis, PAUL J ROACH and Dale L. Bailey

Journal of Nuclear Medicine February 12, 2021, jnumed.120.257659; DOI: https://doi.org/10.2967/jnumed.120.257659
You have access
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
caroline bodet-milin, Alain faivre-chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, delphine Drui, David M Goldenberg, Robert M Sharkey, Jacques Barbet and Francoise Kraeber-Bodere

Journal of Nuclear Medicine February 5, 2021, jnumed.120.252791; DOI: https://doi.org/10.2967/jnumed.120.252791
You have access
Synthesis and evaluation of ¹⁸F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-¹⁸F-fluoro-5α-dihydrotestosterone
Inês F. Antunes, Rutger Dost, Hilde D. Hoving, Aren van Waarde, Rudi A. Dierckx, Douwe F. Samplonius, Wijnand Helfrich, Philip H Elsinga, Erik F de Vries and Igle J. de Jong

Journal of Nuclear Medicine January 30, 2021, jnumed.120.253641; DOI: https://doi.org/10.2967/jnumed.120.253641
You have access
A rapid and safe infusion protocol for lutetium-177 peptide receptor radionuclide therapy
Sander C. Ebbers, Maarten W. Barentsz, Bart de Keizer, Gerard C. Krijger, Marnix G.E.H. Lam and Arthur J.A.T. Braat

Journal of Nuclear Medicine November 27, 2020, jnumed.120.252494; DOI: https://doi.org/10.2967/jnumed.120.252494
You have access
Effects of Repeated ¹³¹I-meta-iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activities in Patients with Metastatic Neuroendocrine Tumors
Keiichiro Yoshinaga, Takashige Abe, Shozo Okamoto, Yuko Uchiyama, Osamu Manabe, Yoichi M. Ito, Naomi Tamura, Natsue Ito, Naho Yoshioka, Komei Washino, Nobuo Shinohara, Nagara Tamaki and Tohru Shiga

Journal of Nuclear Medicine October 16, 2020, jnumed.120.250803; DOI: https://doi.org/10.2967/jnumed.120.250803
You have access
¹⁸F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients
Tina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, Annika Loft, Anne Kiil Berthelsen, Peter Oturai, Jann Mortensen, Birgitte Federspiel, Seppo W Langer and Andreas Kjaer

Journal of Nuclear Medicine October 16, 2020, jnumed.120.244798; DOI: https://doi.org/10.2967/jnumed.120.244798
You have access
First experience using F-18-flubrobenguane PET imaging in patients with the suspicion of pheochromocytoma or paraganglioma
Lukas Kessler, Anna Melissa Schlitter, Markus Kroenke, Alexander von Werder, Robert Tauber, Tobias Maurer, Simon P Robinson, Cesare Orlandi, Michael Herz, Behrooz H Yousefi, Stephan G. Nekolla, Markus Schwaiger, Matthias Eiber and Christoph Rischpler

Journal of Nuclear Medicine August 28, 2020, jnumed.120.248021; DOI: https://doi.org/10.2967/jnumed.120.248021

Main menu

User menu

Search

Oncology: Endocrine